
He was co-Director of the Clinical Electrophysiology Laboratory at Cedars-Sinai Medical Center from 1983-1988.
He currently practices Cardiology and Clinical Electrophysiology in Los Angeles, where he is also Clinical Professor of Medicine at the Geffen School of Medicine at UCLA.

Michael brings an extensive finance and business background to Cardiac Network, having actively participated in several mergers ranging in size from multi-millions to billions of dollars, as well as numerous mergers, acquisitions, and initial public offerings. Michael also brings to Cardiac Network industry-specific experience having previously served as the Director of Finance for Align Technology, Inc., a medical device company engaged in the design, manufacture and marketing of the world’s leading invisible orthodontic product. Prior to Align, Michael served as Corporate Controller for Cardiac Pathways Corporation, where he successfully completed a merger with Boston Scientific Corporation. Michael has also worked in management and consultant roles for companies such as Dolby Laboratories, Hewlett Packard, VeriFone and many other medical device, pharmaceutical and technology companies in the San Francisco Bay area. Michael worked at Ernst & Young, LLP in Los Angeles and San Jose, CA, is a Certified Public Accountant and holds a Masters of Business Administration degree.